Form 8-K ImmunoCellular Therapeut For: May 12

Go back to Form 8-K ImmunoCellular Therapeut For: May 12

ImmunoCellular Therapeutics (IMUC) Tops Q1 EPS by 1c

May 12, 2016 4:59 PM EDT

ImmunoCellular Therapeutics (NYSE: IMUC) reported Q1 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07).

For earnings history and earnings-related data on ImmunoCellular Therapeutics (IMUC) click here.

... More